Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer

Fig. 2

SYNJ2 expression between the LUSC group and control group. A The mRNA expression of SYNJ2 between the LUSC and control groups. *p < 0.05; **p < 0.01; ***p < 0.001; p values are based on the Wilcoxon rank-sum test or t-test. B The forest plot of mRNA expression of SYNJ2 between the LUSC and control groups. C The protein levels of SYNJ2 between the LUSC tissues (C, D) and normal lung tissues (E, F)

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us